News
Eli Lilly's stock dipped after drug trial results, but strong Q2 2025 earnings and market position make it a strong buy. Read ...
Eli Lilly says their obesity pill led to more than 12% weight loss in closely watched late-stage trial, paving way for ...
11h
TipRanks on MSNEli Lilly’s Stock Dips Amid Weight-Loss Pill SetbackEli Lilly & Co has experienced a significant stock price decline of 18.64% over the past week, largely due to disappointing ...
Before receiving Emmy nominations for ‘Nobody Wants This,’ the actress received acclaim for her performance in ‘Veronica Mars ...
Jonathan Lilly, a 1997 Jim Thorpe graduate, was a standout baseball player for the Olympians. Lilly excelled as a three-year ...
11h
MarketBeat on MSNTrump GLP-1 Pilot Program Could Boost Novo Nordisk & Eli LillyThis week, drugmakers had a scare when President Trump threatened to levy tariffs of up to 250% on imported pharmaceuticals.
The past week saw market turbulence, with President Trump's new gold tariffs, Eli Lilly's dramatic stock drop, a weakening ...
Rather, it was the Danish pharmaceutical company's No. 1 rival. Appreciative investors bid up Novo Nordisk's stock in a ...
Pvt Ltd has secured regulatory clearance from the Subject Expert Committee (SEC) under the Central Drugs Standard Control ...
Hyderabad: Sales of weight-loss drugs Wegovy by Danish pharmaceutical giant Novo Nordisk and Mounjaro by U.S.-based Eli Lilly ...
Biocon Biologics Ltd, the biosimilars unit of biopharmaceutical giant Biocon and its largest revenue driver, expects to ...
A leading scientist, a businesswoman and a disease-free patient come together to tell the full story of the promising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results